Tiger Management Corporation

Eterneva specializes in transforming cremated remains into diamonds as lasting memorials. Founded in 2016, it offers personalized experiences for grieving families by creating diamonds in various weights, colors, and cuts, which are then set onto jewelry pieces.

Flutterwave is a global payments technology company that enables businesses worldwide to accept payments from customers globally via web and mobile. It offers services such as Flutterwave Checkout, API for virtual card management, invoicing, payment links, and more, serving industries like gaming, events, transportation, hospitality, and individuals.

ZKH is a digital service platform for industrial products that offers comprehensive supply chain solutions based on an E-commerce platform, digital tools, and intelligent service. Its platform offers a comprehensive selection of industrial accessories, consumables, general equipment, and spare parts. There are 28 product lines and over 4 million SKUs available, including PPE, hand tools, metal processing, fasteners, instruments, chemicals, and so on.

Flywire facilitates global payments for educational institutions and their students worldwide. It offers a secure platform supporting diverse payment methods in over 140 currencies across 240 countries.

Clobotics Co., Ltd. is a technology company specializing in artificial intelligence software solutions tailored for the retail and wind turbine inspection sectors. Founded in November 2016, the company is headquartered in Shanghai, China, with additional offices in Bellevue, Washington, and a branch in Singapore. Clobotics integrates computer vision, artificial intelligence, and data analytics software with various hardware, including drones and mobile applications, to automate labor-intensive operational processes. Its end-to-end solutions facilitate real-time data collection, analysis, and visualization, enabling businesses to enhance efficiency and decision-making through actionable insights. The company has an international research and development team and has filed over 30 patents, highlighting its commitment to innovation in data-driven technologies.

GitLab Inc. is a software development company that provides a comprehensive DevSecOps platform designed to enhance the software development lifecycle. Founded in 2011 and headquartered in San Francisco, California, GitLab offers its services through a single application, which includes tools for version control, continuous integration and deployment, code reviews, issue tracking, and collaboration. This unified platform allows organizations to efficiently plan, build, secure, and deploy software while ensuring visibility and control throughout the process. GitLab serves a diverse clientele, ranging from startups to large enterprises, with an estimated 30 million registered users globally. The company operates on an all-remote model, employing over 1,350 team members across more than 65 countries. GitLab is built on open-source principles and benefits from a vibrant community of developers, continuously driving innovations in the DevOps space.

Jabra Hearing focuses on developing innovative hearing aids tailored for individuals experiencing hearing loss. The company offers technology-enabled devices that connect to users' smartphones through an application, allowing for personalized adjustments in various environments such as offices and restaurants. This app enables users to manage their hearing aid settings, conduct online assessments, and access virtual consultations with audiologists for at-home tuning. Founded in 2018 and based in New York, Jabra Hearing aims to address the significant issue of untreated hearing loss by providing a user-friendly, advanced hearing solution that combines professional care with convenience.

Exosome Diagnostics, Inc. is a biotechnology company focused on developing biofluid-based molecular diagnostic tests to enhance personalized precision healthcare. The company utilizes its proprietary exosome technology to analyze nucleic acids from exosomes found in various biofluids, including blood, urine, and cerebrospinal fluid. This approach allows for high sensitivity and specificity in detecting rare gene transcripts associated with cancers and other serious diseases, enabling non-invasive diagnostic processes that reduce the need for tissue biopsies. One of its key products is the MedOncAlyzer 170, a liquid biopsy pan-cancer panel that assesses exosomal RNA and circulating tumor DNA in a single assay, identifying clinically relevant mutations across multiple cancer types. Additionally, Exosome Diagnostics collaborates with pharmaceutical companies to enhance research and development efforts, from biomarker discovery to the creation of companion diagnostics. Founded in 2008 and based in Cambridge, Massachusetts, the company was previously known as Exosome Theranostics, Inc. and became a subsidiary of Bio-Techne Corporation in 2018.

Exosome Diagnostics, Inc. is a biotechnology company focused on developing biofluid-based molecular diagnostic tests to enhance personalized precision healthcare. The company utilizes its proprietary exosome technology to analyze nucleic acids from exosomes found in various biofluids, including blood, urine, and cerebrospinal fluid. This approach allows for high sensitivity and specificity in detecting rare gene transcripts associated with cancers and other serious diseases, enabling non-invasive diagnostic processes that reduce the need for tissue biopsies. One of its key products is the MedOncAlyzer 170, a liquid biopsy pan-cancer panel that assesses exosomal RNA and circulating tumor DNA in a single assay, identifying clinically relevant mutations across multiple cancer types. Additionally, Exosome Diagnostics collaborates with pharmaceutical companies to enhance research and development efforts, from biomarker discovery to the creation of companion diagnostics. Founded in 2008 and based in Cambridge, Massachusetts, the company was previously known as Exosome Theranostics, Inc. and became a subsidiary of Bio-Techne Corporation in 2018.

Adaptive Biotechnologies Corporation is a commercial-stage company focused on advancing immune-driven medicine by leveraging the biology of the adaptive immune system to enhance disease diagnosis and treatment. Established in 2009 and headquartered in Seattle, Washington, the company offers a range of products and services, including its FDA-authorized clonoSEQ diagnostic test, which is designed for the detection and monitoring of minimal residual disease in patients with specific blood cancers, such as multiple myeloma and chronic lymphocytic leukemia. In addition to clonoSEQ, Adaptive Biotechnologies provides immunoSEQ research services and kits to support scientific research and the discovery of new diagnostic signals. The company also has a pipeline of clinical products aimed at diagnosing and managing various diseases, including cancers, autoimmune disorders, and infectious diseases. It maintains strategic collaborations with notable partners such as Genentech and Microsoft to develop innovative therapies and diagnostic tests.

Mozido is a technology company that offers an integrated platform for cloud-based mobile payment and marketing services. Founded in 2008 and headquartered in Austin, Texas, Mozido provides a suite of solutions aimed at facilitating financial transactions for both banked and unbanked consumers. Its platform combines online payment, shopping, and marketing services with real-time customer behavior analytics, enabling businesses in various sectors—including retail, financial services, consumer packaged goods, and telecommunications—to effectively engage with their customers. The company also specializes in mobile financial transaction services, allowing users to move money, pay bills, and purchase goods and services via mobile and electronic devices. Through its offerings, Mozido supports a diverse range of clients, including financial institutions, mobile network operators, restaurants, municipalities, and governmental entities, enhancing their ability to serve consumers in a connected and mobile-driven environment.